Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Lastly, in the SURPASS-2 trial, of the 1878 patients either prescribed Tirzepatide or Semaglutide, 7 participants experienced pancreatitis
Typical pricing sits in the $200-$400 per month band depending on dose and subscription term, which is roughly 60-80% cheaper than cash-pay brand Zepbound
More Patients, but Uptake Still Small Put this together and we can see that GLP-1 drugs are still on track to become major blockbusters
Over 48 weeks, Retatrutide outperformed both controls and dual agonists on weight and glucose control
US$ 22.67
US$ 28.01
US$ 26.20
US$ 23.76
US$ 20.44
US$ 24.58
US$ 27.06
US$ 21.78
US$ 29.31
US$ 29.29
